Search

everythinglearnresearchcommunity

for

Search:↓

The treatment showed promising hair regrowth in advanced-stage hair loss.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Patients with alopecia areata in the UK face barriers to care, needing better-defined pathways and more education for general practitioners.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Bexarotene gel shows promise as a new treatment for alopecia areata.

Medical practitioners need to understand basic statistics to properly evaluate clinical trials and avoid unethical designs.

Adults with alopecia areata stick to their medication better than those with atopic dermatitis.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Cryotherapy with precise temperature control is a promising treatment for alopecia areata.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Baricitinib may not always prevent relapse in alopecia areata.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Baricitinib is effective for severe alopecia areata but has some side effects.

The trial aims to test if spironolactone is an effective acne treatment for women without the side effects of current treatments.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

The STRIAA tool helps doctors quickly and effectively assess the severity of Alopecia Areata.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Patients and doctors often agree on the severity of eyebrow and eyelash hair loss in severe alopecia areata.